A systematic review of 22 million people finds several mental health conditions, including PTSD, depression and anxiety, are linked to higher acute coronary syndrome risk.
[read the full story...]
Approach Bias Modification didn’t significantly beat standard smoking cessation care, but this may say more about the trial’s power than the intervention itself.
[read the full story...]
A large Australian study suggests that atypical depression is genetically, metabolically and clinically distinct, with poorer response to SSRIs and SNRIs.
[read the full story...]
The EPISODE trial of psychedelic-assisted therapy for ‘treatment-resistant depression’ finds only modest effects, with a few clear responders, but lingering methodological questions.
[read the full story...]
A new study uses AI on brain scans to predict depression. The findings are modest, but the implications go beyond the hospital.
[read the full story...]
A large UK Biobank study tracked sleep in over 77,000 adults. Here’s what the data reveals about age, sex and mood.
[read the full story...]
A small proof-of-principle trial suggests MDMA-assisted therapy may be feasible and effective for depression, but open-label design and a highly pre-treated sample urge caution.
[read the full story...]
Psychedelic therapy looks impressive in trials, but when you account for the placebo effect, how does it really compare to antidepressants?
[read the full story...]
New research suggests that weight gained in the first 12 weeks of antipsychotic treatment is the biggest driver of long-term obesity in psychosis.
[read the full story...]
Can training your brain’s reward circuits strengthen your immune response to vaccination? A new randomised controlled trial offers some fascinating early clues.
[read the full story...]
